Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Privi Speciality ChemicalsNSE:PRIVISCL -1.20%88 3-Year EBITDA Growth Rate is 47.50% as of Jun. 2026, which is 78% above its 10-year median of 26.75. GuruFocus rates NSE:PRIVISCL with a GF Score™ of 88/100 and a GF Value™ of ₹2,630.85 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 1,413 Chemicals companies, Privi Speciality Chemicals ranks better than 92.99% on this metric.
During the past 12 months, Privi Speciality Chemicals's average EBITDA Per Share Growth Rate was 33.60% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 47.50% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 24.10% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 19.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Privi Speciality Chemicals was 117.60% per year. The lowest was -9.90% per year. And the median was 26.75% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Privi Speciality Chemicals 3-Year EBITDA Growth Rate Related Terms
NSE:PRIVISCL vs LIN, SHW, ECL: 3-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, Privi Speciality Chemicals's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Privi Speciality Chemicals 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Privi Speciality Chemicals's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Privi Speciality Chemicals's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 47.50% mean?
Privi Speciality Chemicals (NSE:PRIVISCL) has a 3-Year EBITDA Growth Rate of 47.50% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Privi Speciality Chemicals and its competitors. This is 78% above median its historical median of 26.75. According to the industry distribution chart, Privi Speciality Chemicals ranks #99 out of 1413 companies in the Chemicals industry, placing it in the top 7%.
Is Privi Speciality Chemicals' 3-Year EBITDA Growth Rate too high?
Privi Speciality Chemicals' current 3-Year EBITDA Growth Rate of 47.50% is 78% above median its 10-year median of 26.75. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.70. Privi Speciality Chemicals' value of 47.50% is 6685.7% above this industry median. Based on the distribution chart, Privi Speciality Chemicals ranks #99 out of 1413 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Privi Speciality Chemicals has a GF Score™ of 88/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Privi Speciality Chemicals' 3-Year EBITDA Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, Privi Speciality Chemicals ranks #99 out of 1413 companies for 3-Year EBITDA Growth Rate. This places Privi Speciality Chemicals in the top 7% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 0.70. Privi Speciality Chemicals' value of 47.50% is 6685.7% above this benchmark. While the company's 10-year median is 26.75 vs. the industry median of 0.70, Privi Speciality Chemicals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.70, based on 1,413 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Privi Speciality Chemicals's current 3-Year EBITDA Growth Rate of 47.50% is 6685.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Privi Speciality Chemicals and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Privi Speciality Chemicals's current 3-Year EBITDA Growth Rate is 47.50%, which is 78% above median its own 10-year median of 26.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Privi Speciality Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Privi Speciality Chemicals (NSE:PRIVISCL) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2,630.85, compared to a current price of ₹3,495.60 — trading 32.9% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 47.50%, which is 78% above median its 10-year median of 26.75 and 6685.7% above the Chemicals industry median of 0.70. Privi Speciality Chemicals' overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Privi Speciality Chemicals (NSE:PRIVISCL), the current 3-Year EBITDA Growth Rate is 47.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Privi Speciality Chemicals (NSE:PRIVISCL) Overvalued in 2026?
Based on GuruFocus' analysis, Privi Speciality Chemicals stock appears to be overvalued.
The current stock price of ₹3,495.60 is trading 32.9% above its estimated GF Value™ of ₹2,630.85.
GuruFocus considers Privi Speciality Chemicals to be Significantly Overvalued.
Key valuation signals for NSE:PRIVISCL:
3-Year EBITDA Growth Rate: 47.50% (78% above median its 10-year median of 26.75)
GF Value™: ₹2,630.85 vs. price of ₹3,495.60 (32.9% above fair value)
Industry Position: 6685.7% above the Chemicals median (#99 of 1413)
No single metric tells the full story. See the NSE:PRIVISCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Privi Speciality Chemicals Ltd is engaged in the manufacturing of Speciality Oleo Chemicals, Intermediate Neutraceuticals, and Aromatic Chemicals. Geographically, it derives the majority of its revenues from international markets. It operates in a single segment the Aromatic chemicals segment. Some of its products include Alpha Damascone, Amber Fleur, Citronellyl Acetate, Tetrahydrogeranyl Acetate, Gamma Methyl Ionone, Methyl Ionone, Natural Concentrated Sterols, Dimer Acid, Distilled Fatty Acid, and others.
88GF Score
Get the complete analysis for NSE:PRIVISCL
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PRIVISCL has been successfully added to your 
